Spontaneous platelet aggregation in type IIB tampa von willebrand disease is inhibited by the 52/48-kDa fragment of normal von willebrand factor, which contains the GPIb binding domain
- 1 March 1989
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 30 (3) , 150-153
- https://doi.org/10.1002/ajh.2830300306
Abstract
The association of Type IIB von Willebrand disease (vWD) with chronic persistent thrombocytopenia and spontaneous platelet aggregation has recently been recognized. It has been shown that IIB von Willebrand factor (vWF) can initiate platelet aggregation by binding to the platelet glycoprotein (GP) lb receptor and inducing exposure of the Gpllb/llla fibrinogen receptor. In this study we demonstrate the increased binding of Type IIB Tampa vWF with normal platelets when compared with nonthrombocytopenic Type IIB vWF. Studies further demonstrate that spontaneous platelet aggregation initiated by IIB Tampa vWF can be blocked by a 52/48‐kDa fragment of normal vWF, which contains the binding domain.Keywords
This publication has 17 references indexed in Scilit:
- von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib.Published by Elsevier ,1986
- Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation.Proceedings of the National Academy of Sciences, 1985
- Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody.Journal of Clinical Investigation, 1985
- Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.Journal of Clinical Investigation, 1985
- Type IIB Tampa: a variant of von Willebrand disease with chronic thrombocytopenia, circulating platelet aggregates, and spontaneous platelet aggregationBlood, 1985
- Endotoxin-mediated inhibition of human platelet aggregationThrombosis Research, 1984
- Isoelectric focusing of human von Willebrand factor in urea-agarose gelsBlood, 1983
- von Willebrand disease associated with familial thrombocytopenia and increased ristocetin-induced platelet aggregationAmerican Journal of Hematology, 1981
- Familial occurrence of von Willebrandʼs disease, thrombocytopenia, and severe gastrointestinal bleedingThe Lancet Healthy Longevity, 1973
- Preparation of Suspensions of Washed Platelets from HumansBritish Journal of Haematology, 1972